Pierre P Major

Pierre P Major

UNVERIFIED PROFILE

Are you Pierre P Major?   Register this Author

Register author
Pierre P Major

Pierre P Major

Publications by authors named "Pierre P Major"

Are you Pierre P Major?   Register this Author

13Publications

270Reads

33Profile Views

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

N Engl J Med 2017 02;376(5):417-428

From Massachusetts General Hospital and Harvard Medical School, Boston (W.U.S., N.M.H., A.L.Z.); NRG Oncology Statistics and Data Management Center (W.S., J.J.D., S.L.P.) and Einstein Medical Center (K.L.Z.), Philadelphia; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON (H.R.L., P.P.M., M.P.P.), Hospital Notre-Dame du Centre Hospitalier de l'Université de Montréal (J.-P.B.) and McGill University Health Centre (L.S.), Montreal, and Tom Baker Cancer Centre, Calgary, AB (A.G.B.) - all in Canada; Indiana University, Indianapolis (D.J.G.); Tulane University, New Orleans (O.S.); Mayo Clinic, Rochester, MN (T.M.P.); Medical College of Wisconsin, Milwaukee (C.A.F.L.); University of Michigan, Ann Arbor (F.Y.F.); University of Vermont Medical Center, Burlington (R.D.L.); Radiation Oncology Center, Sacramento (S.A.R.), and Cedars-Sinai Medical Center, Los Angeles (H.M.S.) - both in California; Wayne Radiation Oncology, Goldsboro, NC (K.J.K.); and the University of Chicago, Chicago (J.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444881PMC
February 2017

Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens.

Front Immunol 2014 6;5:191. Epub 2014 May 6.

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen , Netherlands ; Department of Medical Oncology, Radboud University Medical Center , Nijmegen , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2014.00191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018526PMC
June 2014

Effect of bisphosphonates on pain and quality of life in patients with bone metastases.

Nat Clin Pract Oncol 2009 Mar 3;6(3):163-74. Epub 2009 Feb 3.

Serviço de Oncologia, Hospital de Santa Maria, Instituto de Medicina Molecular, Lisboa, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://projects.itn.pt/Radiopharmaceutical_S/BP/LCostaNatCli
Web Search
http://www.nature.com/doifinder/10.1038/ncponc1323
Publisher Site
http://dx.doi.org/10.1038/ncponc1323DOI Listing
March 2009

An optimized clinical regimen for the oncolytic virus PV701.

Clin Cancer Res 2007 Feb;13(3):977-85

Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1817DOI Listing
February 2007

Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.

Curr Opin Mol Ther 2003 Dec;5(6):618-24

Wellstat Biologics Corporation, 930 Clopper Road, Gaithersburg, MD 20878, USA.

View Article

Download full-text PDF

Source
December 2003

Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.

Am J Clin Oncol 2002 Dec;25(6 Suppl 1):S10-8

Hamilton Regional Cancer Center, Department of Medicine, McMaster University, 699 Concession St., Hamilton, Ontario, Canada L8V 5C2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-200212001-00003DOI Listing
December 2002